Examkin

Soru

Zorluk: OrtaPreventive Care and Screening

A 64-year-old man presents to the clinic for a health maintenance examination. He feels well and has no history of cardiovascular disease, chest pain, shortness of breath, or transient ischemic attacks. His medical history includes hypertension, hyperlipidemia, and type 2 diabetes mellitus. Current medications include lisinopril, metformin, and atorvastatin. Blood pressure is 128/78 mm Hg, and heart rate is 72/min. Recent laboratory studies show a hemoglobin A1c of 7.1% and an LDL cholesterol of 85 mg/dL. His calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk is 14%. The patient read a health newsletter recommending daily aspirin to prevent heart attacks and asks if he should start taking it. Which of the following is the most appropriate recommendation regarding antiplatelet therapy for this patient?

  1. Advise against initiating any antiplatelet therapyCevap
  2. B
    Initiate low-dose aspirin therapy due to his elevated atherosclerotic cardiovascular disease risk
  3. C
    Initiate low-dose aspirin therapy concurrently with a proton pump inhibitor
  4. D
    Order a coronary artery calcium score to determine the need for aspirin therapy
  5. E
    Initiate clopidogrel therapy as an alternative primary preventive agent

Cevap

Advise against initiating any antiplatelet therapy.
The correct recommendation is to advise against initiating any antiplatelet therapy. According to the updated 2022 United States Preventive Services Task Force (USPSTF) guidelines, initiating low-dose aspirin for the primary prevention of cardiovascular disease is not recommended in adults aged 60 years or older (Grade D recommendation). Although this patient has multiple risk factors (diabetes, hypertension) and a 10-year ASCVD risk greater than 10%, current evidence shows that for patients in this age group without established cardiovascular disease, the increased risk of significant bleeding (such as gastrointestinal bleeding and intracranial hemorrhage) cancels out or outweighs the potential cardiovascular benefit. He is already appropriately managed with a statin, ACE inhibitor, and metformin.

Adım Adım Çözüm

1
Determine the indication for aspirin in this patient.
The patient has no history of cardiovascular disease, so the indication would be primary prevention.
Secondary prevention (e.g., prior MI or stroke) always requires antiplatelet therapy, while primary prevention depends on specific risk-benefit profiles.
2
Evaluate the patient's age and risk factors against current evidence-based guidelines.
The patient is 64 years old with a 14% ASCVD risk.
Age is the primary determining factor in the updated 2022 USPSTF guidelines for aspirin initiation.
3
Apply the guideline recommendation.
The USPSTF recommends against initiating low-dose aspirin for the primary prevention of cardiovascular disease in adults 60 years or older.
In this age cohort, the risk of serious bleeding (gastrointestinal and intracranial) outweighs the potential cardiovascular benefits of initiation.
4
Select the corresponding management step.
Advise against initiating any antiplatelet therapy.
Withholding aspirin is the guideline-concordant, evidence-based next step.

Anahtar Kavram

The USPSTF recommends against initiating low-dose aspirin use for the primary prevention of cardiovascular disease in adults 60 years or older due to bleeding risks outweighing benefits.
Bu soruyu puanla

Konular

Preventive Care and Screening

Bu konudan daha fazla soru